Joris Winderickx
Corporate Officer/Principal presso reMYND NV
Profilo
Joris Winderickx is the founder of reMYND NV, where he currently serves as the Scientific Advisor since 2012.
He founded the company in 2002.
Dr. Winderickx is also the founder of Royal Flemish Chemical Society.
Dr. Winderickx's former job includes being a Director at ADx NeuroSciences NV.
Additionally, he worked as a Professor at Katholieke Universiteit Leuven.
Dr. Winderickx's education includes a doctorate degree from Katholieke Universiteit Leuven.
Posizioni attive di Joris Winderickx
| Società | Posizione | Inizio |
|---|---|---|
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Corporate Officer/Principal | 30/05/2012 |
Precedenti posizioni note di Joris Winderickx
| Società | Posizione | Fine |
|---|---|---|
| Royal Flemish Chemical Society | Fondatore | - |
ADx NeuroSciences NV
 ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Direttore/Membro del Consiglio | - |
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - |
Formazione di Joris Winderickx
| Katholieke Universiteit Leuven | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Health Technology |
| Royal Flemish Chemical Society |
- Borsa valori
- Insiders
- Joris Winderickx
